Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
absorb, Affordable, beneficiary, BioTox, book, branded, buyer, Canadian, candidate, case, chose, compensatory, comprising, core, customary, customer, demand, dictate, digit, diminished, director, disposal, disposed, distraction, domestic, double, Education, eliminated, essential, Government, Gulf, Horizon, impose, India, influence, inherently, insignificant, joint, lack, Latin, length, likelihood, mandated, marketplace, merge, minimum, North, noteholder, personnel, portfolio, portion, post, power, priority, proforma, qualitative, quickly, Reconciliation, regulate, regulated, representation, residual, Samm, separately, similarly, Sorrento, space, structure, structured, subordinated, subsequent, subsequently, Switzerland, tinea, TP, travel, understood, unknown, USD, variable, VIE, Vitaros®from, Vitaros®product, warrantholder, wholly, withholding
Removed:
accompany, acquirer, addressed, addressing, administered, advanced, advisory, agency, aggressively, allocated, amortizing, animal, announced, anticancer, anticipation, apparent, appealing, approvable, assigned, assist, assuming, assurance, August, authorization, Bayer, blood, borrowing, breast, CAC, canceling, carcinogenicity, carcinoma, characterized, chemotherapy, circulation, cited, cleared, CMC, cold, collectible, collectively, color, Committee, commonly, communication, comparator, compatible, conduct, conducted, conducting, consist, controlled, covering, decided, decision, demonstrated, dependence, dependent, dermatological, design, designation, directly, disease, doxorubicin, emotional, equipment, expanded, extend, failed, fashion, favorable, final, formation, formulation, forward, front, gain, gave, global, GLP, glucose, HCC, healthcare, healthy, hepatocellular, hour, human, Iceland, incorporating, IND, infusion, ingredient, injectable, injection, insufficient, insulin, intended, Interpretable, key, kidney, large, letter, licensed, licensee, listed, lung, male, medical, met, midsize, mild, moderate, molecule, mouse, move, moving, mutual, NEXAVAR, obligated, observed, obtained, October, opportunity, orphan, ovarian, overhead, package, paclitaxel, parallel, partnership, patent, path, pharmacokinetic, pivotal, PK, prescribed, proceed, program, promising, proposed, randomized, range, reach, reached, recently, registered, release, remain, renal, representing, requested, response, responsible, Sanofi, scaling, scientific, sexually, showed, side, similar, single, skin, small, solution, specifically, spent, Squibb, standard, strongly, subcutaneously, Submission, submit, successor, suddenly, supported, systemic, Taxol, TgAC, therapeutic, therapy, toenail, tolerability, toxicity, transfer, transgenic, transmission, transmitted, treat, treating, trial, uncertainty, underlying, validate, validation, variety, varying, vivo, volume
Filing tables
Filing exhibits
SEELQ similar filings
Filing view
External links